For example, transforming growth factor-β (TGF-β) and interleukin-2 (IL-2), which, respectively, suppress local tumor immune responses and amplify the activation of melanoma-specific T-cell responses, can be combined to treat metastatic melanoma [55]. The gene discussed is TGFB1; the disease is neoplasm.